Potential Plasticity of the Mannoprotein Repertoire Associated to


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
18 May 2020
Historique:
received: 29 02 2020
revised: 04 05 2020
accepted: 13 05 2020
entrez: 24 5 2020
pubmed: 24 5 2020
medline: 12 2 2021
Statut: epublish

Résumé

To date,

Identifiants

pubmed: 32443484
pii: molecules25102348
doi: 10.3390/molecules25102348
pmc: PMC7287972
pii:
doi:

Substances chimiques

Glycoproteins 0
Membrane Glycoproteins 0
Virulence Factors 0
mannoproteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Agence Nationale de la Recherche
ID : 11BSVB6016 08 / ANR-10-INBS-08

Références

PLoS One. 2016 Jun 09;11(6):e0157043
pubmed: 27280414
Microb Cell Fact. 2011 Dec 20;10:110
pubmed: 22185589
Electrophoresis. 2017 Jan;38(1):162-189
pubmed: 27757981
J Glob Infect Dis. 2017 Oct-Dec;9(4):129-130
pubmed: 29302145
Chem Rev. 2013 Apr 10;113(4):2668-732
pubmed: 23531120
J Proteome Res. 2009 Feb;8(2):721-33
pubmed: 19196185
Front Cell Infect Microbiol. 2014 Sep 17;4:133
pubmed: 25279354
J Proteomics. 2014 Jan 31;97:296-306
pubmed: 23702328
OMICS. 2010 Aug;14(4):401-18
pubmed: 20443730
Mol Microbiol. 2003 Apr;48(1):77-84
pubmed: 12657046
Infect Immun. 1999 Nov;67(11):5567-72
pubmed: 10531201
BMC Microbiol. 2009 May 14;9:93
pubmed: 19442300
PLoS Pathog. 2014 Oct 30;10(10):e1004471
pubmed: 25356793
Nat Commun. 2017 Nov 3;8(1):1280
pubmed: 29097667
Anal Chem. 2017 Jan 3;89(1):389-413
pubmed: 28105826
Trends Biotechnol. 2017 Jul;35(7):598-609
pubmed: 28527536
Peptides. 2012 Dec;38(2):208-16
pubmed: 23000473
Mol Cell Proteomics. 2011 Dec;10(12):M111.011627
pubmed: 21969609
Sci Rep. 2019 Feb 27;9(1):2927
pubmed: 30814666
Infect Immun. 1995 Feb;63(2):580-4
pubmed: 7822025
Mol Cell Proteomics. 2013 May;12(5):1180-91
pubmed: 23345537
Mol Biosyst. 2010 May;6(5):775-81
pubmed: 20567761
J Biol Chem. 2015 May 22;290(21):13321-43
pubmed: 25825498
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12989-94
pubmed: 14569030
Methods Mol Biol. 2017;1503:235-264
pubmed: 27743371
Biochim Biophys Acta. 1975 Jan 13;381(1):175-84
pubmed: 1111583
Nature. 2013 Jul 11;499(7457):178-83
pubmed: 23823726
Front Immunol. 2014 Aug 11;5:361
pubmed: 25157249
Infect Immun. 1995 Aug;63(8):2846-53
pubmed: 7622204
Tuberculosis (Edinb). 2019 Mar;115:1-13
pubmed: 30948163
Clin Exp Immunol. 1989 Sep;77(3):378-83
pubmed: 2478323
Mol Microbiol. 1994 May;12(3):491-504
pubmed: 8065266
Science. 2005 Aug 5;309(5736):941-3
pubmed: 16081738
Cell Immunol. 2018 Jun;328:70-78
pubmed: 29625705
Acta Crystallogr D Biol Crystallogr. 2013 Oct;69(Pt 10):1981-94
pubmed: 24100317
FEBS Lett. 2000 May 19;473(3):358-62
pubmed: 10818240
PLoS One. 2011 Mar 22;6(3):e18175
pubmed: 21445360
Infect Immun. 1993 Jan;61(1):260-7
pubmed: 8418047
Anal Chem. 2018 Jul 3;90(13):8065-8071
pubmed: 29741879
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7521-6
pubmed: 20368441
Mol Cell Proteomics. 2007 Sep;6(9):1621-37
pubmed: 17533220
Mol Microbiol. 2010 Apr;76(2):348-64
pubmed: 20233304
J Biol Chem. 2003 May 2;278(18):16423-32
pubmed: 12517764
Front Microbiol. 2015 Feb 10;6:6
pubmed: 25713560
Sci Rep. 2017 Aug 11;7(1):7913
pubmed: 28801649
J Immunol. 2008 May 1;180(9):5833-42
pubmed: 18424702
EMBO J. 1996 Jul 15;15(14):3547-54
pubmed: 8670858
J Mol Med (Berl). 2012 Mar;90(3):285-98
pubmed: 21993523
Microb Pathog. 2016 Nov;100:285-292
pubmed: 27765619
Cell Host Microbe. 2013 May 15;13(5):602-612
pubmed: 23684311
Immunol Rev. 2015 Mar;264(1):25-45
pubmed: 25703550
Front Microbiol. 2016 May 31;7:813
pubmed: 27303394
Proteomics. 2011 Aug;11(16):3380-9
pubmed: 21751370
PLoS Pathog. 2014 Sep 18;10(9):e1004376
pubmed: 25232742
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4602-7
pubmed: 15070764
OMICS. 2013 Oct;17(10):502-9
pubmed: 23952586
Nat Rev Drug Discov. 2017 Jul;16(7):457-471
pubmed: 28337021
PLoS Pathog. 2011 Sep;7(9):e1002251
pubmed: 21980284
Sci Data. 2015 Mar 31;2:150010
pubmed: 25977815
Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5322-6
pubmed: 8506381
J Proteomics. 2011 Dec 21;75(2):502-10
pubmed: 21920479
Sci Rep. 2015 May 15;5:10281
pubmed: 25975873
OMICS. 2010 Aug;14(4):487-99
pubmed: 20726804
mBio. 2017 Jan 17;8(1):
pubmed: 28096490
J Bacteriol. 1996 May;178(9):2498-506
pubmed: 8626314
Biochem J. 2005 Dec 15;392(Pt 3):615-24
pubmed: 16092920
J Proteomics. 2015 Aug 3;126:189-99
pubmed: 26070398
Nat Commun. 2017 Sep 5;8(1):438
pubmed: 28874712
Biochem Biophys Res Commun. 2010 Jan 1;391(1):679-84
pubmed: 19944079
PLoS Pathog. 2013;9(10):e1003705
pubmed: 24130497
Microb Cell Fact. 2019 Jan 19;18(1):11
pubmed: 30660186
PLoS One. 2012;7(9):e46225
pubmed: 23029442
J Biol Chem. 2007 Feb 23;282(8):5133-42
pubmed: 17158455
Sci Rep. 2018 Feb 1;8(1):2117
pubmed: 29391424
EMBO J. 2013 May 15;32(10):1478-88
pubmed: 23584533
J Biol Chem. 1999 Nov 5;274(45):32023-30
pubmed: 10542234
Glycobiology. 2009 Jan;19(1):38-51
pubmed: 18842962
Mass Spectrom (Tokyo). 2017;6(Spec Iss):S0064
pubmed: 28337402
Scand J Immunol. 2015 Jan;81(1):46-55
pubmed: 25359607
Sci Rep. 2017 Mar 08;7:43682
pubmed: 28272507
Amino Acids. 2011 Jul;41(2):321-8
pubmed: 20652609
J Proteome Res. 2017 Apr 7;16(4):1632-1645
pubmed: 28241730
Mol Cell Proteomics. 2010 May;9(5):1006-21
pubmed: 20093276
Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6560-5
pubmed: 23550160

Auteurs

Laure Tonini (L)

Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, 31077 Toulouse, France.

Bashir Sadet (B)

Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, 31077 Toulouse, France.

Alexandre Stella (A)

Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, 31077 Toulouse, France.

David Bouyssié (D)

Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, 31077 Toulouse, France.

Jérôme Nigou (J)

Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, 31077 Toulouse, France.

Odile Burlet-Schiltz (O)

Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, 31077 Toulouse, France.

Michel Rivière (M)

Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, 31077 Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH